Literature DB >> 10605000

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.

J R Maxwell1, A Weinberg, R A Prell, A T Vella.   

Abstract

This report defines a cell surface receptor (OX40) expressed on effector CD4 T cells, which when engaged in conjunction with a danger signal, rescues Ag-stimulated effector cells from activation-induced cell death in vivo. Specifically, three signals were necessary to promote optimal generation of long-lived CD4 T cell memory in vivo: Ag, a danger signal (LPS), and OX40 engagement. Mice treated with Ag or superantigen (SAg) alone produced very few SAg-specific T cells. OX40 ligation or LPS stimulation, enhanced SAg-driven clonal expansion and the survival of responding T cells. However, when SAg was administered with a danger signal at the time of OX40 ligation, a synergistic effect was observed which led to a 60-fold increase in the number of long-lived, Ag-specific CD4 memory T cells. These data lay the foundation for the provision of increased numbers of memory T cells which should enhance the efficacy of vaccine strategies for infectious diseases, or cancer, while also providing a potential target (OX40) to limit the number of auto-Ag-specific memory T cells in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10605000     DOI: 10.4049/jimmunol.164.1.107

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  T cell apoptosis and reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; John Kappler; Philippa Marrack
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.

Authors:  Jennifer L Gommerman; Keith Giza; Stuart Perper; Irene Sizing; Apinya Ngam-Ek; Cheryl Nickerson-Nutter; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

3.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Authors:  Lara Myers; Chikara Takahashi; Robert S Mittler; Robert J Rossi; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

4.  Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.

Authors:  Hiroshi Kato; Hidefumi Kojima; Naoto Ishii; Hidenori Hase; Yutaka Imai; Takashi Fujibayashi; Kazuo Sugamura; Testuji Kobata
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

5.  OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.

Authors:  Robert J Snelgrove; Megan M Cornere; Lorna Edwards; Belinda Dagg; James Keeble; Angela Rodgers; Daphne E Lyonga; Graham R Stewart; Douglas B Young; Barry Walker; Tracy Hussell
Journal:  J Infect Dis       Date:  2012-02-07       Impact factor: 5.226

Review 6.  Modulation of antitumor responses by dendritic cells.

Authors:  Johannes Vieweg; Andrew Jackson
Journal:  Springer Semin Immunopathol       Date:  2005-01

7.  OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.

Authors:  Naomi Kitamura; Satoshi Murata; Tomoyuki Ueki; Eiji Mekata; R Todd Reilly; Elizabeth M Jaffee; Tohru Tani
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

8.  T cell responses: naive to memory and everything in between.

Authors:  Nathan D Pennock; Jason T White; Eric W Cross; Elizabeth E Cheney; Beth A Tamburini; Ross M Kedl
Journal:  Adv Physiol Educ       Date:  2013-12       Impact factor: 2.288

Review 9.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

10.  Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.

Authors:  Peyman Rajabi; Mahsa Alaee; Kazem Mousavizadeh; Ali Samadikuchaksaraei
Journal:  Inflamm Res       Date:  2012-07-31       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.